Abstract
Purpose or Objective Dose-escalated chemoradiation (CRT, preceded by a boost of 5x3Gy) did not result in increased complete response rates in locally advanced rectal cancer (LARC) patients as compared to standard CRT in the randomized RECTAL-BOOST trial (Clinicaltrials.gov NCT01951521). However, dose-escalated CRT initiated significantly more tumor regression (Mandard 1-2), suggesting
... read more